Almac Doubles Global 2-8 °C Cold Room Capacity in Response to Increasing Biologics Demand
Almac has announced a significant investment to more than double the existing capacity of their 2–8 °C clinical supply labelling cold room facilities in the Group’s European and US-based facilities.
Additional dedicated temperature and humidity controlled labelling suites have been installed and are now live at Almac’s headquarter sites situated in Craigavon (UK), Souderton (PA) and Durham (NC) increasing their capacity to label temperature sensitive investigational products. This expansion represents the latest development in the company’s investment initiatives designed to meet growing client demand for specific services including a significant upsurge in clinical studies for biosimilar and biological investigational products.
The expansion of Almac’s cold room facilities adds significant capacity or clients requiring the development of valuable biologically sensitive investigational products, whilst complementing the company’s existing clinical supply chain management services.
Commenting on this latest expansion, Robert Dunlop, Managing Director of Almac’s Clinical Services Business Unit remarked: "We have witnessed significant growth in the biologics market in the past 12 months and this latest investment reflects both our on-going commitment to meeting the demands of the clinical trial market, as well as our ability to expand and adapt successfully to key developments within the pharmaceutical and biotech industries. These are exciting times for Almac as we continue to increase our range of services to deliver world class solutions to our global client base."
The cold room facilities expansion follows on from other recently announced investments including £54 million spent on the company’s pharmaceutical development and clinical services operations. This is in addition to the establishment of regional operations centres through strategic investments in Singapore and Japan geared towards meeting increasing customer demand in the Asia Pacific region.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance